Bath & Body Works, Inc. (NYSE:BBWI) to Issue $0.20 Quarterly Dividend

Bath & Body Works, Inc. (NYSE:BBWIGet Free Report) announced a quarterly dividend on Friday, February 7th,RTT News reports. Stockholders of record on Friday, February 21st will be paid a dividend of 0.20 per share on Friday, March 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.23%.

Bath & Body Works has increased its dividend payment by an average of 21.1% annually over the last three years. Bath & Body Works has a dividend payout ratio of 20.1% meaning its dividend is sufficiently covered by earnings. Research analysts expect Bath & Body Works to earn $3.65 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 21.9%.

Bath & Body Works Price Performance

Shares of BBWI opened at $35.89 on Friday. The stock has a market capitalization of $7.77 billion, a PE ratio of 8.75, a price-to-earnings-growth ratio of 0.90 and a beta of 1.83. The business’s fifty day moving average price is $37.75 and its 200 day moving average price is $33.66. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period last year, the firm posted $0.48 EPS. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, research analysts anticipate that Bath & Body Works will post 3.26 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

BBWI has been the subject of a number of research reports. JPMorgan Chase & Co. lifted their target price on Bath & Body Works from $39.00 to $41.00 and gave the company a “neutral” rating in a research note on Friday, January 24th. Deutsche Bank Aktiengesellschaft upped their price objective on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Telsey Advisory Group reiterated an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a research note on Monday, November 25th. TD Cowen upped their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Finally, Argus reiterated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $43.19.

View Our Latest Research Report on Bath & Body Works

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

See Also

Dividend History for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.